-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Tengjun Biotechnology Corp. quarterly/annual Revenues history and growth rate from Q1 2022 to Q1 2023.
- Tengjun Biotechnology Corp. Revenues for the quarter ending March 31, 2023 was $8.52M, a 98.8% increase year-over-year.
- Tengjun Biotechnology Corp. Revenues for the twelve months ending March 31, 2023 was $154M.
- Tengjun Biotechnology Corp. annual Revenues for 2022 was $150M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)